vs
渤健（BIIB）与西部数据（WDC）财务数据对比。点击上方公司名可切换其他公司
西部数据的季度营收约是渤健的1.3倍（$3.0B vs $2.3B），西部数据净利率更高（61.1% vs -2.1%，领先63.2%），西部数据同比增速更快（31.5% vs -7.1%），过去两年渤健的营收复合增速更高（-0.2% vs -6.6%）
渤健是总部位于美国马萨诸塞州剑桥市的跨国生物技术企业，专注于神经系统疾病治疗领域。公司核心产品包括用于多发性硬化症的特菲达、万立能等多款药物，以及治疗脊髓性肌萎缩症的诺西那生钠、治疗弗里德赖希共济失调的Skyclarys，致力于为神经疾病和罕见病患者提供创新疗法。
西部数据（简称WD）是总部位于美国加利福尼亚州圣何塞的知名数据存储企业，成立于1970年，是全球最大的硬盘驱动器（HDD）制造商之一，产品覆盖消费级、企业级等多元存储场景，为全球客户提供高性能、高可靠性的存储解决方案。
BIIB vs WDC — 直观对比
营收规模更大
WDC
是对方的1.3倍
$2.3B
营收增速更快
WDC
高出38.7%
-7.1%
净利率更高
WDC
高出63.2%
-2.1%
两年增速更快
BIIB
近两年复合增速
-6.6%
损益表 — Q4 FY2025 vs Q2 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $2.3B | $3.0B |
| 净利润 | $-48.9M | $1.8B |
| 毛利率 | 78.3% | 45.7% |
| 营业利润率 | -2.5% | 30.1% |
| 净利率 | -2.1% | 61.1% |
| 营收同比 | -7.1% | 31.5% |
| 净利润同比 | -118.3% | 254.2% |
| 每股收益（稀释后） | $-0.35 | $4.73 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收BIIBWDC
| Q1 26 | — | $3.0B | ||
| Q4 25 | $2.3B | $2.8B | ||
| Q3 25 | $2.5B | — | ||
| Q2 25 | $2.6B | $-1.2B | ||
| Q1 25 | $2.4B | $2.3B | ||
| Q4 24 | $2.5B | $4.3B | ||
| Q3 24 | $2.5B | $4.1B | ||
| Q2 24 | $2.5B | $3.8B |
净利润BIIBWDC
| Q1 26 | — | $1.8B | ||
| Q4 25 | $-48.9M | $1.2B | ||
| Q3 25 | $466.5M | — | ||
| Q2 25 | $634.8M | $282.0M | ||
| Q1 25 | $240.5M | $520.0M | ||
| Q4 24 | $266.7M | $594.0M | ||
| Q3 24 | $388.5M | $493.0M | ||
| Q2 24 | $583.6M | $39.0M |
毛利率BIIBWDC
| Q1 26 | — | 45.7% | ||
| Q4 25 | 78.3% | 43.5% | ||
| Q3 25 | 73.4% | — | ||
| Q2 25 | 77.1% | — | ||
| Q1 25 | 74.1% | 39.8% | ||
| Q4 24 | 76.2% | 35.4% | ||
| Q3 24 | 74.1% | 37.9% | ||
| Q2 24 | 77.8% | 35.9% |
营业利润率BIIBWDC
| Q1 26 | — | 30.1% | ||
| Q4 25 | -2.5% | 28.1% | ||
| Q3 25 | 22.0% | — | ||
| Q2 25 | 28.1% | — | ||
| Q1 25 | 12.8% | 33.1% | ||
| Q4 24 | 11.9% | 19.9% | ||
| Q3 24 | 18.3% | 18.1% | ||
| Q2 24 | 28.3% | 5.7% |
净利率BIIBWDC
| Q1 26 | — | 61.1% | ||
| Q4 25 | -2.1% | 41.9% | ||
| Q3 25 | 18.4% | — | ||
| Q2 25 | 24.0% | -24.4% | ||
| Q1 25 | 9.9% | 22.7% | ||
| Q4 24 | 10.9% | 13.9% | ||
| Q3 24 | 15.8% | 12.0% | ||
| Q2 24 | 23.7% | 1.0% |
每股收益（稀释后）BIIBWDC
| Q1 26 | — | $4.73 | ||
| Q4 25 | $-0.35 | $3.07 | ||
| Q3 25 | $3.17 | — | ||
| Q2 25 | $4.33 | $0.72 | ||
| Q1 25 | $1.64 | $1.42 | ||
| Q4 24 | $1.82 | $1.63 | ||
| Q3 24 | $2.66 | $1.35 | ||
| Q2 24 | $4.00 | $0.15 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | — | $2.0B |
| 总债务越低越好 | $6.3B | $4.7B |
| 股东权益账面价值 | $18.3B | $7.1B |
| 总资产 | $29.4B | $15.6B |
| 负债/权益比越低杠杆越低 | 0.34× | 0.65× |
8季度趋势，按日历期对齐
现金及短期投资BIIBWDC
| Q1 26 | — | $2.0B | ||
| Q4 25 | — | $2.0B | ||
| Q3 25 | — | — | ||
| Q2 25 | — | $2.1B | ||
| Q1 25 | — | $3.5B | ||
| Q4 24 | — | $2.3B | ||
| Q3 24 | — | $1.7B | ||
| Q2 24 | — | $1.9B |
总债务BIIBWDC
| Q1 26 | — | $4.7B | ||
| Q4 25 | $6.3B | $4.7B | ||
| Q3 25 | $6.3B | — | ||
| Q2 25 | $6.3B | $4.7B | ||
| Q1 25 | $4.5B | $7.3B | ||
| Q4 24 | $6.3B | $7.4B | ||
| Q3 24 | $4.5B | $7.4B | ||
| Q2 24 | $6.3B | $7.4B |
股东权益BIIBWDC
| Q1 26 | — | $7.1B | ||
| Q4 25 | $18.3B | $5.9B | ||
| Q3 25 | $18.2B | — | ||
| Q2 25 | $17.6B | $5.3B | ||
| Q1 25 | $17.0B | $5.2B | ||
| Q4 24 | $16.7B | $12.1B | ||
| Q3 24 | $16.4B | $11.6B | ||
| Q2 24 | $15.9B | $10.8B |
总资产BIIBWDC
| Q1 26 | — | $15.6B | ||
| Q4 25 | $29.4B | $14.4B | ||
| Q3 25 | $29.2B | — | ||
| Q2 25 | $28.3B | $14.0B | ||
| Q1 25 | $28.0B | $16.4B | ||
| Q4 24 | $28.0B | $25.5B | ||
| Q3 24 | $28.3B | $24.8B | ||
| Q2 24 | $26.8B | $24.2B |
负债/权益比BIIBWDC
| Q1 26 | — | 0.65× | ||
| Q4 25 | 0.34× | 0.80× | ||
| Q3 25 | 0.35× | — | ||
| Q2 25 | 0.36× | 0.89× | ||
| Q1 25 | 0.27× | 1.42× | ||
| Q4 24 | 0.38× | 0.61× | ||
| Q3 24 | 0.28× | 0.64× | ||
| Q2 24 | 0.40× | 0.69× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $511.9M | — |
| 自由现金流经营现金流 - 资本支出 | $468.0M | — |
| 自由现金流率自由现金流/营收 | 20.5% | — |
| 资本支出强度资本支出/营收 | 1.9% | — |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $2.1B | — |
8季度趋势，按日历期对齐
经营现金流BIIBWDC
| Q1 26 | — | — | ||
| Q4 25 | $511.9M | $672.0M | ||
| Q3 25 | $1.3B | — | ||
| Q2 25 | $160.9M | $746.0M | ||
| Q1 25 | $259.3M | $508.0M | ||
| Q4 24 | $760.9M | $403.0M | ||
| Q3 24 | $935.6M | $34.0M | ||
| Q2 24 | $625.8M | $366.0M |
自由现金流BIIBWDC
| Q1 26 | — | — | ||
| Q4 25 | $468.0M | $599.0M | ||
| Q3 25 | $1.2B | — | ||
| Q2 25 | $134.3M | $675.0M | ||
| Q1 25 | $222.2M | $379.0M | ||
| Q4 24 | $721.6M | $287.0M | ||
| Q3 24 | $900.6M | $-62.0M | ||
| Q2 24 | $592.3M | $250.0M |
自由现金流率BIIBWDC
| Q1 26 | — | — | ||
| Q4 25 | 20.5% | 21.3% | ||
| Q3 25 | 48.4% | — | ||
| Q2 25 | 5.1% | -58.5% | ||
| Q1 25 | 9.1% | 16.5% | ||
| Q4 24 | 29.4% | 6.7% | ||
| Q3 24 | 36.5% | -1.5% | ||
| Q2 24 | 24.0% | 6.6% |
资本支出强度BIIBWDC
| Q1 26 | — | — | ||
| Q4 25 | 1.9% | 2.6% | ||
| Q3 25 | 1.8% | — | ||
| Q2 25 | 1.0% | -6.2% | ||
| Q1 25 | 1.5% | 5.6% | ||
| Q4 24 | 1.6% | 2.7% | ||
| Q3 24 | 1.4% | 2.3% | ||
| Q2 24 | 1.4% | 3.1% |
现金转化率BIIBWDC
| Q1 26 | — | — | ||
| Q4 25 | — | 0.57× | ||
| Q3 25 | 2.73× | — | ||
| Q2 25 | 0.25× | 2.65× | ||
| Q1 25 | 1.08× | 0.98× | ||
| Q4 24 | 2.85× | 0.68× | ||
| Q3 24 | 2.41× | 0.07× | ||
| Q2 24 | 1.07× | 9.38× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
BIIB
| Products | $1.7B | 73% |
| Tysabri Product | $244.5M | 11% |
| AVONEX | $119.2M | 5% |
| SKYCLARYS | $88.9M | 4% |
| Alzheimers Collaboration | $47.1M | 2% |
| IMRALDI | $43.5M | 2% |
| TECFIDERA | $36.9M | 2% |
| PLEGRIDY | $24.7M | 1% |
| QALSODY | $7.8M | 0% |
| BYOOVIZ | $4.3M | 0% |
WDC
| Cloud | $2.7B | 89% |
| Client Devices | $176.0M | 6% |
| Consumer | $168.0M | 6% |
